Detalhe da pesquisa
1.
Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure.
N Engl J Med
; 384(2): 105-116, 2021 01 14.
Artigo
Inglês
| MEDLINE | ID: mdl-33185990
2.
Omecamtiv Mecarbil in Chronic Heart Failure With Reduced Ejection Fraction: Rationale and Design of GALACTIC-HF.
JACC Heart Fail
; 8(4): 329-340, 2020 04.
Artigo
Inglês
| MEDLINE | ID: mdl-32035892
3.
Comparison of Outcome Adjudication by Investigators and by a Central End Point Committee in Heart Failure Trials: Experience of the SHIFT Heart Failure Study.
Circ Heart Fail
; 13(7): e006720, 2020 07.
Artigo
Inglês
| MEDLINE | ID: mdl-32580655
4.
Omecamtiv mecarbil in chronic heart failure with reduced ejection fraction: GALACTIC-HF baseline characteristics and comparison with contemporary clinical trials.
Eur J Heart Fail
; 22(11): 2160-2171, 2020 11.
Artigo
Inglês
| MEDLINE | ID: mdl-32985088
5.
Report of the European Society of Cardiology Cardiovascular Round Table regulatory workshop update of the evaluation of new agents for the treatment of acute coronary syndrome: Executive summary.
Eur Heart J Acute Cardiovasc Care
; 8(8): 745-754, 2019 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-27357206